Table 3 Ocular complications and loss of best-corrected visual acuity for eyes of patients with ocular syphilis.
From: Influence of gender on clinical presentation, management practices and outcomes of ocular syphilis
Complication | All (n = 204) | Women (n = 50) | Men (n = 154) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Number at risk | Number of events | Incidence rate (per eye-year) | Poisson Exact CI 95% | Number at risk | Number of events | Incidence rate (per eye-year) | Poisson Exact CI 95% | Number at risk | Number of events | Incidence rate (per eye-year) | Poisson Exact CI 95% | |
Cataract | 185 | 16 | 0.18 | 0.10–0.28 | 42 | 3 | 0.16 | 0.03–0.37 | 143 | 13 | 0.2 | 0.11–0.34 |
Epiretinal membrane | 200 | 11 | 0.09 | .04–0.16 | 50 | 2 | 0.06 | 0.01–0.21 | 150 | 9 | 0.11 | 0.05–0.21 |
Glaucoma/ocular hypertension | 202 | 11 | 0.10 | 0.05–0.17 | 50 | 1 | 0.03 | 0.001–0.16 | 152 | 9 | 0.11 | 0.05–0.22 |
Optic nerve atrophy | 204 | 9 | 0.07 | 0.03–0.14 | 50 | 2 | 0.06 | 0.01–0.21 | 154 | 7 | 0.08 | 0.03–0.17 |
Rhegmatogenous retinal detachment | 204 | 6 | 0.05 | 0.02–0.11 | 50 | 0 | 0 | NA | 154 | 6 | 0.07 | 0.03–0.15 |
Cystoid macular edema | 191 | 0 | 0 | NA | 47 | 0 | 0 | NA | 144 | 0 | 0 | NA |
Choroidal neovascularization | 200 | 0 | 0 | NA | 48 | 0 | 0 | NA | 152 | 0 | 0 | NA |
Retinal vascular occlusionb | 202 | 0 | 0 | NA | 50 | 0 | 0 | NA | 152 | 0 | 0 | NA |
Visual acuity | ||||||||||||
≤ 20/50 | 69 | 4 | 0.10 | 0.03–0.25 | 10 | 0 | 0 | NA | 59 | 4 | 0.11 | 0.03–0.29 |
≤ 20/200 | 126 | 5 | 0.06 | 0.02–0.14 | 33 | 2 | 0.08 | 0.01–0.03 | 93 | 3 | 0.05 | 0.01–0.15 |
